Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GC/GEJC”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Testing effectiveness (Phase 2)Looking for participantsNCT07474324
What this trial is testing

Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical Trial

Who this might be right for
GC/GEJC
The First Affiliated Hospital with Nanjing Medical University 124
Testing effectiveness (Phase 2)Active Not RecruitingNCT03979131
What this trial is testing

Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC)

Who this might be right for
Gastroesophageal Junction AdenocarcinomaStomach Neoplasms
Vall d'Hebron Institute of Oncology 40
Testing effectiveness (Phase 2)Looking for participantsNCT07070232
What this trial is testing

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 980
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06439550
What this trial is testing

Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJC

Who this might be right for
HER2-positive Gastric Cancer
The First Affiliated Hospital of Zhengzhou University 42
Testing effectiveness (Phase 2)Looking for participantsNCT06742411
What this trial is testing

XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC

Who this might be right for
Gastric (Stomach) Cancer
West China Hospital 57
Testing effectiveness (Phase 2)UnknownNCT06202716
What this trial is testing

Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscore

Who this might be right for
Gastric Cancer
Nanfang Hospital, Southern Medical University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06157996
What this trial is testing

Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore

Who this might be right for
Gastric Cancer
Nanfang Hospital, Southern Medical University 92
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06238167
What this trial is testing

Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJC

Who this might be right for
Gastric Cancer
First Affiliated Hospital of Wenzhou Medical University 40
Not applicableStudy completedNCT06452329
What this trial is testing

Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Bristol-Myers Squibb 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT04817826
What this trial is testing

TremelImumab aNd Durvalumab For the Non-operatIve Management (NOM) of MSI-high Resectable GC/GEJC.

Who this might be right for
Gastric CancerMicrosatellite Instability
Gruppo Oncologico del Nord-Ovest 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06684158
What this trial is testing

Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC

Who this might be right for
GC/GEJC
The First Affiliated Hospital with Nanjing Medical University 70
Large-scale testing (Phase 3)Looking for participantsNCT04342910
What this trial is testing

Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC

Who this might be right for
Gastric Cancer
Jiangsu HengRui Medicine Co., Ltd. 550
Large-scale testing (Phase 3)Active Not RecruitingNCT04592913
What this trial is testing

Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer

Who this might be right for
Gastrointestinal NeoplasmsEsophagogastric Junction
AstraZeneca 957
Testing effectiveness (Phase 2)Looking for participantsNCT06506292
What this trial is testing

A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)

Who this might be right for
Adebrelimab (SHR-1316)XELOXGC/GEJC
Tianjin Medical University Cancer Institute and Hospital 25
Testing effectiveness (Phase 2)UnknownNCT04890392
What this trial is testing

Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC

Who this might be right for
Advanced Gastric CancerAdvanced Gastroesophageal Junction Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 20
Large-scale testing (Phase 3)Looking for participantsNCT07518147
What this trial is testing

A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 438